Kingworld Medicines Group Ltd. (HK:1110) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Kingworld Medicines Group Ltd. has announced its Board of Directors as of September 1, 2024, which includes both executive and independent non-executive members. The board comprises seven individuals with Mr. Zhao Li Sheng as the Chairman and roles distributed across three key committees: Audit, Remuneration, and Nomination. This restructuring reflects Kingworld’s commitment to strong governance and oversight in its operations.
For further insights into HK:1110 stock, check out TipRanks’ Stock Analysis page.